Ascend Biopharmaceuticals

Ascend is a cancer immunotherapy company developing drugs for the treatment of primary, recurrent, and metastatic cancers. Cancer consists of many different cell types that can influence and regulate the local tumor microenvironment to promote tumor growth. Ascend's strategic focus is on targeting these key cells and transforming the host microenvironment from one that supports tumor growth to one that leads to cancer eradication.